Mitochondrial disease
Gene: MT-TS2
MODERATE by ClinGen.
At least 7 individuals reported. Affected individuals had varying clinical features including cataracts, retinal dystrophy, hearing loss, myopathy, ataxia, seizures, global developmental delay, diabetes, Wolff-Parkinson-White arrhythmia, hypertrophic cardiomyopathy, and hypogonadotropic hypogonadism. Lab investigations revealed elevated blood lactate and elevated creatine kinase. Muscle biopsy, when performed, generally showed reduced activities of complexes I, I+III, III, and/or IV. Brain imaging was normal in some cases. In one individual brain imaging revealed changes in the basal ganglia and diffuse atrophy with an enlarged cisterna magna and in another showed changes in the cerebral white matter.
Heteroplasmy levels were variable – some individuals had the highest levels in muscle with the variant being undetectable in other tissues while others had the variant present at homoplasmy in multiple tissues. Northern blotting and single fiber testing further supported variant pathogenicity.Created: 29 Sep 2025, 6:02 p.m. | Last Modified: 29 Sep 2025, 6:02 p.m.
Panel Version: 0.1067
Sources: Expert listCreated: 19 Apr 2020, 2:12 p.m.
Mode of inheritance
MITOCHONDRIAL
Phenotypes
Mitochondrial disease (MONDO:0044970), MT-TS2-related
Publications
Phenotypes for gene: MT-TS2 were changed from MERRF; MELAS; Cerebellar ataxia to Mitochondrial disease (MONDO:0044970), MT-TS2-related
Publications for gene: MT-TS2 were set to
Tag mtDNA tag was added to gene: MT-TS2.
Gene: mt-ts2 has been classified as Green List (High Evidence).
Gene: mt-ts2 has been classified as Green List (High Evidence).
gene: MT-TS2 was added gene: MT-TS2 was added to Mitochondrial disease. Sources: Expert list Mode of inheritance for gene gene: MT-TS2 was set to MITOCHONDRIAL Phenotypes for gene: MT-TS2 were set to MERRF; MELAS; Cerebellar ataxia Review for gene: MT-TS2 was set to GREEN